BERETTA SIMONE

Roberti, R., Politi, C., Anzellotti, F., Belcastro, V., Beretta, S., Boero, G., et al. (2026). Lacosamide is Associated with a Higher Treatment Persistence at 12 Months than Brivaracetam and Perampanel Despite Similar Efficacy. NEUROLOGY AND THERAPY, 15(1), 213-235 [10.1007/s40120-025-00860-5]. Dettaglio

Impellizzeri, M., Paone, P., Pauletto, G., Nilo, A., Beretta, S., Salmaggi, A., et al. (2026). Perampanel as add-on in high-grade glioma–related epilepsy: Seizure control and QoL in a prospective, multicenter, real-world 6-month follow-up study. EPILEPSIA OPEN, 11(4 (August 2026)), 1137-1148 [10.1002/epi4.70274]. Dettaglio

Leitinger, M., Beretta, S. (2026). Pathophysiology and Prognostic Significance of Myoclonus in Hypoxic-Ischemic Encephalopathy. JOURNAL OF CLINICAL NEUROPHYSIOLOGY, 43(5), 403-409 [10.1097/WNP.0000000000001272]. Dettaglio

Cerulli Irelli, E., Roberti, R., Borioni, M., Anzellotti, F., Belcastro, V., Beretta, S., et al. (2026). Comparative Effectiveness of Brivaracetam, Cenobamate, Lacosamide, and Perampanel in Focal Epilepsy. JAMA NEUROLOGY, 83(4), 320-328 [10.1001/jamaneurol.2025.5625]. Dettaglio

Fare, M., Bianchi, E., Benina, G., Lucchi, G., Mercenari, M., Innocenti, F., et al. (2026). Effectiveness and safety of endovascular therapy compared to intravenous thrombolysis in acute ischaemic stroke due to medium-vessel occlusions: a real-world multicentre study from the Italian SITS registry. EUROPEAN STROKE JOURNAL, 11(3) [10.1093/esj/aakag020]. Dettaglio